Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros













Base de datos
Intervalo de año de publicación
1.
Bioorg Med Chem Lett ; 93: 129433, 2023 09 01.
Artículo en Inglés | MEDLINE | ID: mdl-37557923

RESUMEN

The α7 nicotinic acetylcholine receptor is a calcium permeable, ligand-gated ion channel that modulates synaptic transmission in the hippocampus, thalamus, and cerebral cortex. Previously disclosed work described PNU-120596 that acts as a powerful positive allosteric modulator of the α7 nicotinic acetylcholine receptor. The initial structure-activity relationships around PNU-120596 were gleaned from screening a large thiazole library. Independent systematic examination of the aryl and heteroaryl groups resulted in compounds with enhanced potency and improved physico-chemical properties culminating in the identification of 16 (PHA-758454). In the presence of acetylcholine, 16 enhanced evoked currents in rat hippocampal neurons. In a rat model of impaired sensory gating, treatment with 16 led to a reversal of the gating deficit in a dose-dependent manner. These results demonstrate that aryl heteroaryl ureas, like compound 16, may be useful tools for continued exploration of the unique biology of the α7 nicotinic acetylcholine receptor.


Asunto(s)
Receptores Nicotínicos , Receptor Nicotínico de Acetilcolina alfa 7 , Ratas , Animales , Hipocampo , Compuestos de Fenilurea/química , Isoxazoles/farmacología , Isoxazoles/química , Regulación Alostérica
2.
Bioorg Med Chem ; 14(24): 8219-48, 2006 Dec 15.
Artículo en Inglés | MEDLINE | ID: mdl-17011782

RESUMEN

A novel set of azabicyclic aryl amides have been identified as potent and selective agonists of the alpha7 nAChR. A two-pronged approach was taken to improve the potential hERG liability of previously disclosed alpha7 nAChR agonist, PNU-282,987, while maintaining the compound's other desirable pharmacological properties. The first approach involved further exploration of the aryl carboxylic acid fragment of PNU-282,987, while the second approach focused on modification of the azabicyclic amine portion of PNU-282,987. The best compounds from each series are characterized by rapid brain penetration, good oral bioavailability in rat, and demonstrate in vivo efficacy in a rat P50 auditory sensory gating assay. At least one analog from each series (1h, 1o, 2a, 9a, and 18a) shows an improved hERG safety profile over PNU-282,987.


Asunto(s)
Encéfalo/metabolismo , Diseño de Fármacos , Agonistas Nicotínicos/farmacología , Receptores Nicotínicos/química , Animales , Bungarotoxinas , Células Cultivadas , Electrofisiología , Potenciales Evocados Auditivos/efectos de los fármacos , Hipocampo/efectos de los fármacos , Activación del Canal Iónico/efectos de los fármacos , Estructura Molecular , Actividad Motora/efectos de los fármacos , Neuronas/efectos de los fármacos , Agonistas Nicotínicos/síntesis química , Agonistas Nicotínicos/química , Técnicas de Placa-Clamp , Ratas , Ratas Sprague-Dawley , Relación Estructura-Actividad , Sinapsis/efectos de los fármacos , Sinapsis/fisiología , Receptor Nicotínico de Acetilcolina alfa 7
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA